205 WEST 28TH STREET, NEW YORK, NY, UNITED STATES, 10001
国家
美国
上市日期
2025-07-02
财年截止
十二月
流通股数
2156万
CIK
--
官方网址
--
1RT Acquisition Corp. 公司总部位于纽约州纽约市。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
营业支出
2026-06-30
$14.52万
2026-03-31
$17.25万
2025-12-31
$11.7万
2025-09-30
$28.51万
净利润
2026-06-30
$142.64万
2026-03-31
$137.38万
2025-12-31
$156.32万
2025-09-30
$139.81万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$0.06
2026-03-31
$0.06
2025-12-31
$0.07
2025-09-30
$0.07
息税折旧摊销前利润
2026-06-30
-$14.52万
2026-03-31
-$17.25万
2025-12-31
-$11.7万
2025-09-30
$139.81万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$0
$0
$0
$0
营业支出
$14.52万
$17.25万
$11.7万
$28.51万
净利润
$142.64万
$137.38万
$156.32万
$139.81万
净利润率
--
--
--
--
每股收益
$0.06
$0.06
$0.07
$0.07
息税折旧摊销前利润
-$14.52万
-$17.25万
-$11.7万
$139.81万
有效税率
--
--
--
--
常见问题
ONCH represents the publicly traded equity of Onconetix, Inc., a company focused on developing and commercializing diagnostic and therapeutic solutions in oncology and related healthcare markets. Shares trade on a U.S. exchange under the ticker ONCH. Investors commonly track ONCH to gain exposure to the company's product pipeline, strategic partnerships, and commercial-stage efforts. Because it is a smaller-cap healthcare name, ONCH can be sensitive to clinical, regulatory, and financing developments.
The latest ONCH stock price is shown on the ONCH stock detail page, along with real-time or delayed quotes, daily price changes, volume, and charting data. For the most current price, you should refer to that page or your brokerage platform. If you need precise figures such as intraday highs, lows, and recent trades, rely on the live market data displayed there rather than fixed or historical numbers.
Several factors can influence ONCH stock, including clinical trial results, regulatory decisions, product commercialization progress, partnership or licensing news, and capital-raising activities. Broader healthcare-sector sentiment, changes in reimbursement or drug-pricing policy, and general market conditions can also affect the shares. Because ONCH has a relatively limited revenue base, company-specific announcements often have an outsized impact on the stock's trading behavior compared with larger, more diversified healthcare peers.
Valuation for ONCH is typically assessed using metrics such as price-to-sales, price-to-book, enterprise value, and cash position, since early-stage healthcare companies may not have meaningful earnings. Analysts may also consider pipeline potential, addressable market size, and partnership economics, though these are qualitative and harder to benchmark. Investors should review the latest ONCH data on the page and compare it with peer companies, while recognizing that clinical-stage names can trade on future prospects rather than current fundamentals.
You can buy ONCH stock through a brokerage account that offers access to U.S. equity markets. Once your account is funded, you can place a market or limit order for ONCH shares during regular trading hours. Some brokers also support extended-hours trading and fractional shares, subject to their policies. Before trading, check commissions, order types, and any eligibility requirements, and confirm the latest ONCH quote on the stock detail page for current pricing.
Key risks include clinical and regulatory uncertainty, dependence on a limited number of product candidates, potential need for additional financing, and competition from larger healthcare companies. ONCH may also face manufacturing, reimbursement, and commercialization risks. Because the company is relatively small, its shares can be more volatile and less liquid than larger peers, and negative news on trials, partnerships, or financials could disproportionately affect the stock price.